<?xml version="1.0"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="ru">
	<id>https://transhumanist.ru/index.php?action=history&amp;feed=atom&amp;title=NINL</id>
	<title>NINL - История изменений</title>
	<link rel="self" type="application/atom+xml" href="https://transhumanist.ru/index.php?action=history&amp;feed=atom&amp;title=NINL"/>
	<link rel="alternate" type="text/html" href="https://transhumanist.ru/index.php?title=NINL&amp;action=history"/>
	<updated>2026-11-09T08:55:38Z</updated>
	<subtitle>История изменений этой страницы в вики</subtitle>
	<generator>MediaWiki 1.43.6</generator>
	<entry>
		<id>https://transhumanist.ru/index.php?title=NINL&amp;diff=5620&amp;oldid=prev</id>
		<title>OdysseusBot: Новая страница: «Ninein-like protein [KIAA0980] [NLP]  ==Publications==  {{medline-entry |title=Novel image-novel location object recognition task sensitive to age-related cogniti...»</title>
		<link rel="alternate" type="text/html" href="https://transhumanist.ru/index.php?title=NINL&amp;diff=5620&amp;oldid=prev"/>
		<updated>2021-05-12T13:52:30Z</updated>

		<summary type="html">&lt;p&gt;Новая страница: «Ninein-like protein [KIAA0980] [NLP]  ==Publications==  {{medline-entry |title=Novel image-novel location object recognition task sensitive to age-related cogniti...»&lt;/p&gt;
&lt;p&gt;&lt;b&gt;Новая страница&lt;/b&gt;&lt;/p&gt;&lt;div&gt;Ninein-like protein [KIAA0980] [NLP]&lt;br /&gt;
&lt;br /&gt;
==Publications==&lt;br /&gt;
&lt;br /&gt;
{{medline-entry&lt;br /&gt;
|title=Novel image-novel location object recognition task sensitive to age-related cognitive decline in nondemented elderly.&lt;br /&gt;
|pubmed-url=https://pubmed.ncbi.nlm.nih.gov/21234692&lt;br /&gt;
|abstract=Traditional tests used in the clinic to identify dementia, such as the mini-mental state examination (MMSE), are useful to identify severe cognitive impairments but might be less sensitive to detect more subtle age-related cognitive changes. Previously, the novel image-novel location ([[NINL]]) object recognition test was shown to be sensitive to detect effects of apolipoprotein E4, a risk factor for developing age-related cognitive decline and Alzheimer&amp;#039;s disease, in nondemented elderly. In the present longitudinal study, performance on the MMSE and the [[NINL]] tests were compared over a 4-year period. Individual [[NINL]] scores over this period were highly correlated. In addition, while MMSE scores did not change over the 4-year period, [[NINL]] scores did. In a final testing session of a subset of the participants, [[NINL]] scores correlated with logical memory and word recall lists, cognitive tasks used to detect dementia in the clinic, as well as clinical dementia rating scales. These results support that the [[NINL]] might be a valuable tool to assess age-related cognitive decline.&lt;br /&gt;
|mesh-terms=* Aged&lt;br /&gt;
* Aged, 80 and over&lt;br /&gt;
* Aging&lt;br /&gt;
* Apolipoprotein E4&lt;br /&gt;
* Biomarkers&lt;br /&gt;
* Cognition Disorders&lt;br /&gt;
* Humans&lt;br /&gt;
* Longitudinal Studies&lt;br /&gt;
* Neuropsychological Tests&lt;br /&gt;
* Oregon&lt;br /&gt;
* Psychiatric Status Rating Scales&lt;br /&gt;
* Risk Factors&lt;br /&gt;
&lt;br /&gt;
|full-text-url=https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3260359&lt;br /&gt;
}}&lt;br /&gt;
{{medline-entry&lt;br /&gt;
|title=Effects of epsilon4 on object recognition in the non-demented elderly.&lt;br /&gt;
|pubmed-url=https://pubmed.ncbi.nlm.nih.gov/20044903&lt;br /&gt;
|abstract=Previously we reported that apolipoprotein E (ApoE) epsilon4 negatively affects performance in the novel-image-novel-location ([[NINL]]) object recognition test in healthy non-demented elderly human study participants. In this study, the participants were invited to return for testing sessions 6 and 18 months after the baseline session. Using a longitudinal study design, effects of epsilon4 on [[NINL]] test performance were assessed in study &amp;quot;dropouts&amp;quot;, participants that did not return for the second and/or third session(s), and &amp;quot;finishers&amp;quot;, participants that returned for all sessions. There were effects of epsilon4 on dropout rates and [[NINL]] total scores as well as sub-scores in both dropouts and finishers. [[NINL]] total score was a predictor of epsilon4 participant dropout. Compared to non-epsilon4 dropouts, epsilon4 dropouts had lower [[NINL]] scores. In contrast, epsilon4 finishers had higher [[NINL]] scores than non-epsilon4 finishers. Thus, the [[NINL]] test could be a valuable tool in detecting pre-clinical signs of age-related cognitive impairments, particularly those associated with epsilon4 risk.&lt;br /&gt;
|mesh-terms=* Aged&lt;br /&gt;
* Aged, 80 and over&lt;br /&gt;
* Aging&lt;br /&gt;
* Apolipoprotein E4&lt;br /&gt;
* Chi-Square Distribution&lt;br /&gt;
* Cognition&lt;br /&gt;
* Cortisone&lt;br /&gt;
* Female&lt;br /&gt;
* Genotype&lt;br /&gt;
* Geriatric Assessment&lt;br /&gt;
* Humans&lt;br /&gt;
* Logistic Models&lt;br /&gt;
* Longitudinal Studies&lt;br /&gt;
* Male&lt;br /&gt;
* Memory&lt;br /&gt;
* Middle Aged&lt;br /&gt;
* Neuropsychological Tests&lt;br /&gt;
* Oregon&lt;br /&gt;
* Patient Dropouts&lt;br /&gt;
* Phenotype&lt;br /&gt;
* Recognition, Psychology&lt;br /&gt;
* Risk Assessment&lt;br /&gt;
* Risk Factors&lt;br /&gt;
* Saliva&lt;br /&gt;
* Testosterone&lt;br /&gt;
* Time Factors&lt;br /&gt;
&lt;br /&gt;
|full-text-url=https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4849126&lt;br /&gt;
}}&lt;/div&gt;</summary>
		<author><name>OdysseusBot</name></author>
	</entry>
</feed>